Loading...

A Double-Blind Placebo Controlled Comparison of the Efficacy and Safety of Short Acting Intramuscular Olanzapine, Short Acting Intramuscular Lorazepam and Intramuscular Placebo in Treating Agitation in Patients with Dementia of the Alzheimer’s Type, Vascular Dementia and Mixed Dementia - Vivli | NLM Dataset Catalog